Ophthalmic Infections

  1. Al-Badriyeh D, Leung L, Davies GE, et al.  Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.  Ann Pharmacother 2009;43:1139-42.
  2. Al-Badriyeh D, Leung L, Davies GE, et al.  Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.  Ann Pharmacother 2009;43:2103-7.
  3. American Academy of Ophthalmology Cornea/External Disease Panel.  Preferred Practice Pattern® Guidelines.  Bacterial Keratitis.  San Francisco, CA:  American Academy of Ophthalmology; 2013.  Available at www.aao.org/ppp.
  4. Auran JD, Starr MB, Jakobiec FA.  Acanthamoeba keratitis: a review of the literature.  Cornea 1987;6:2-26.
  5. Bacon AS, Frazer DG, Dart JKG, et al.  A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.  Eye 1993;7:719-25.
  6. Barron BA et al: Herpetic eye disease study group, a controlled trail of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994;101:1871-82.
  7. Baum J. Infections of the eye. Clin Infect Dis 1995;21:479-86.
  8. Beers M, Berkow R. The Merck manual of diagnosis and therapy 17th ed. West Point, PA: Merck & Co. Inc;1999:704-19.
  9. Berger ST, Mondino BJ, Hoft RH, et al.  Successful medical management of Acanthamoeba keratitis.  Am J Ophthalmol 1990;110:395-403.
  10. Boruchoff A, Boruchoff S.  Infections of the lacrimal system.  Infect Dis Clin N Am 1992;6:925-32.
  11. Callegan MC, Engelbert M, Parke II DW, et al.  Bacterial endophthalmitis:  epidemiology, therapeutics, and bacterium-host interactions.  Clin Micro Rev 2002;15:111-24.
  12. Donahue S, Khoury J, Kowalski R. Common ocular infections. A prescriber’s guide. Drugs 1996:52:526-40.
  13. Elder MJ, Dart JKG.  Chemotherapy for Acanthamoeba keratitis.  Lancet 1995;345:791-3.
  14. Fanella S, Singer A, Embree J.  Presentation and management of pediatric orbital cellulitis.  Can J Infect Dis Med Microbiol 2011;22:97-100.
  15. Friesen A. Sight for sore eyes. Pharm Pract 1997;13:71-78.
  16. Gilbert DN, Moellering RC, Eliopoulos GM, eds.  The Sanford guide to antimicrobial therapy 2012. Sperryville, VA:  Antimicrobial Therapy, Inc. 2012.
  17. Haimovici R, Roussel T. Treatment of gonococcal conjunctivitis with single intramuscular ceftriaxone. Am J Ophthalmol 1989;107:511-14.
  18. Hay J, Kirkness CM, Seal DV, et al.  Drug resistance and Acanthamoeba keratitis:  the quest for alternative antiprotozoal chemotherapy.  Eye 1994;8,555-63.
  19. Hershey B, Roth T. Orbital infections. Seminars in ultrasound, CT, and MRI 1997;18:448-59.
  20. Illingworth CD, Cook SD, Karabatsas CH, et al.  Acanthamoeba keratitis:  risk factors and outcome.  Brit J Ophthalmol 1995;79:1078-82.
  21. Kumar R, Lloyd D.  Recent advances in the treatment of Acanthamoeba keratitis.  Clin Infect Dis 2002;35:434-41.
  22. Larkin DFP, Kilvington S, Dart JKG.  Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.  Ophthalmol 1992;99:185-91.
  23. Leibowitz HM.  Primary care:  the red eye.  N Engl J Med 2000;343:345-51.
  24. Lindquist TD.  Treatment of Acanthamoeba keratitis.  Cornea 1998;17:11-16.
  25. Martinez-Vazquez C, Fernandez-Ulloa J, Bordon J, et al.  Candida albicans endophthalmitis in brown heroin addicts:  response to early vitrectomy preceded and followed by antifungal therapy.  Clin Infect Dis 1998;27:1130-3.
  26. McCulley J, Dougherty J, Deneau D. Classification of chronic blepharitis. Ophthalmology 1982;89:1173-80.
  27. Moore DL, MacDonald NE; Canadian Pediatric Society, Infectious Diseases and Immunization Committee.  Preventing ophthalmia neonatorum.  Paediatr Child Health 2015;20:93-6.
  28. Mueller JB, McStay CM.  Ocular infection and inflammation.  Emerg Med Clin N Am 2008;26:57-72.
  29. Nageswaran S, Woods CR, Benjamin DK, et al.  Orbital cellulitis in children.  Pediatr Infect Dis J 2006;25:695-9.
  30. O’Brien T, Green W. Section M. Eye infections.  In:  Mandell GL, Douglas RG, Bennett JE, eds.  Principles and practice of infectious diseases. 4th ed. New York, NY: Churchill Livingstone;1995;1103-36.
  31. Peek MJ, Bajoria R, et al.  Chemotherapy for acanthamoeba keratitis.  Lancet 1995;345:
  32. Pettit T, Holland G. Chronic keratoconjunctivitis associated with ocular adenovirus infection. Am J Ophthalmol 1979;88:748-51.
  33. Peyman G, Bassili S. A practical guideline for management of endophthalmitis. Ophthalmic Surg 1995;26:294-303.
  34. Pierre-Yves R, Adenis JP.  Comparative review of topical ophthalmic antibacterial preparations. Drugs 2001;61:175-85.
  35. Reese R, Betts R.  A practical approach to infectious diseases. 3rd ed. Boston/Toronto/London: Little, Brown and Company 1991;146-65.
  36. Riddell J, Comer GM, Kauffman CA.  Treatment of endogenous fungal endophthalmitis:  focus on new antifungal agents.  Clin Infect Dis 2011;52:648-53.
  37. Seal DV, Hay J, Kirkness CM.  Chlorhexidine or polyhexamethylene biguanide for Acanthamoeba keratitis.  Lancet 1995;345:136.
  38. Seal DV, Hay J, Kirkness CM, et al.  Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.  Eye 1996;10:413-21.
  39. Sunaric-Megevand G, Pournaras C. Current approach to postoperative endophthalmitis. Br J Ophthalmol 1997:81:1006-15.
  40. Tasman W, Jaeger E.  Duane’s Clinical Ophthalmology. Vol 4. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins;1998.
  41. Thomas PA, Geraldine P.  Infectious keratitis.  Curr Opin Infect Dis 2007;20:129-41.
  42. Virgil D, Liggett P.  Vitreoretinal surgery of the injured eye. Philadelphia, PA: Lippincott-Raven Publishers; 1999.
  43. Wilhelmus K, et al: Herpetic eye disease study group, a controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 1994;101:1883-96.